Omnicell ROE 2010-2024 | OMCL
Current and historical return on equity (ROE) values for Omnicell (OMCL) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Omnicell ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-09-30 |
$-0.02B |
$1.23B |
-1.41% |
| 2024-06-30 |
$-0.02B |
$1.20B |
-1.68% |
| 2024-03-31 |
$-0.02B |
$1.19B |
-1.78% |
| 2023-12-31 |
$-0.02B |
$1.19B |
-1.71% |
| 2023-09-30 |
$-0.03B |
$1.19B |
-2.94% |
| 2023-06-30 |
$-0.02B |
$1.16B |
-2.01% |
| 2023-03-31 |
$-0.02B |
$1.14B |
-1.51% |
| 2022-12-31 |
$0.01B |
$1.13B |
0.54% |
| 2022-09-30 |
$0.05B |
$1.14B |
4.31% |
| 2022-06-30 |
$0.06B |
$1.09B |
5.42% |
| 2022-03-31 |
$0.07B |
$1.08B |
6.48% |
| 2021-12-31 |
$0.08B |
$1.15B |
7.13% |
| 2021-09-30 |
$0.08B |
$1.11B |
7.63% |
| 2021-06-30 |
$0.06B |
$1.05B |
5.97% |
| 2021-03-31 |
$0.04B |
$1.01B |
3.70% |
| 2020-12-31 |
$0.03B |
$0.97B |
3.50% |
| 2020-09-30 |
$0.04B |
$0.92B |
4.31% |
| 2020-06-30 |
$0.05B |
$0.89B |
5.73% |
| 2020-03-31 |
$0.07B |
$0.88B |
8.35% |
| 2019-12-31 |
$0.06B |
$0.85B |
7.73% |
| 2019-09-30 |
$0.05B |
$0.81B |
7.22% |
| 2019-06-30 |
$0.05B |
$0.77B |
6.85% |
| 2019-03-31 |
$0.04B |
$0.73B |
5.96% |
| 2018-12-31 |
$0.04B |
$0.68B |
6.33% |
| 2018-09-30 |
$0.06B |
$0.62B |
9.41% |
| 2018-06-30 |
$0.05B |
$0.59B |
8.95% |
| 2018-03-31 |
$0.04B |
$0.58B |
8.58% |
| 2017-12-31 |
$0.03B |
$0.55B |
6.48% |
| 2017-09-30 |
$0.01B |
$0.47B |
2.01% |
| 2017-06-30 |
$0.00B |
$0.45B |
0.69% |
| 2017-03-31 |
$-0.00B |
$0.44B |
0.00% |
| 2016-12-31 |
$0.01B |
$0.43B |
2.38% |
| 2016-09-30 |
$0.01B |
$0.43B |
2.18% |
| 2016-06-30 |
$0.02B |
$0.41B |
3.71% |
| 2016-03-31 |
$0.03B |
$0.41B |
6.23% |
| 2015-12-31 |
$0.03B |
$0.40B |
7.76% |
| 2015-09-30 |
$0.03B |
$0.39B |
8.07% |
| 2015-06-30 |
$0.03B |
$0.40B |
7.88% |
| 2015-03-31 |
$0.03B |
$0.41B |
7.73% |
| 2014-12-31 |
$0.03B |
$0.39B |
7.94% |
| 2014-09-30 |
$0.03B |
$0.38B |
7.61% |
| 2014-06-30 |
$0.03B |
$0.38B |
8.00% |
| 2014-03-31 |
$0.03B |
$0.37B |
7.68% |
| 2013-12-31 |
$0.02B |
$0.35B |
7.04% |
| 2013-09-30 |
$0.02B |
$0.36B |
6.96% |
| 2013-06-30 |
$0.02B |
$0.33B |
6.98% |
| 2013-03-31 |
$0.02B |
$0.32B |
5.60% |
| 2012-12-31 |
$0.02B |
$0.31B |
5.41% |
| 2012-09-30 |
$0.01B |
$0.30B |
4.83% |
| 2012-06-30 |
$0.01B |
$0.29B |
3.51% |
| 2012-03-31 |
$0.01B |
$0.29B |
4.27% |
| 2011-12-31 |
$0.01B |
$0.28B |
4.00% |
| 2011-09-30 |
$0.01B |
$0.28B |
2.96% |
| 2011-06-30 |
$0.01B |
$0.27B |
2.25% |
| 2011-03-31 |
$0.01B |
$0.27B |
1.90% |
| 2010-12-31 |
$0.01B |
$0.27B |
1.93% |
| 2010-09-30 |
$0.01B |
$0.26B |
1.98% |
| 2010-06-30 |
$0.01B |
$0.26B |
2.01% |
| 2010-03-31 |
$0.00B |
$0.25B |
1.64% |
| 2009-12-31 |
$0.00B |
$0.24B |
0.42% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$1.964B |
$1.147B |
|
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
|
